rTMS-concurrent Behavioral Priming for Reducing Smoking Cravings

Status Recruiting

Clinical Trial Summary

The objective of this pilot clinical trial is to test the effects of different types of thinking strategies at the time of repetitive Transcranial Magnetic Stimulation (rTMS), applied to the left Dorsolateral Prefrontal Cortex (DLPFC), on smoking craving and brain activity. Participants will be individuals with moderate to high smoking dependence (smoking at least 8 cigarettes a day) who have no intention of quitting in the next 3 months and are eligible to have rTMS and functional magnetic resonance imaging (fMRI). The main objectives of the trial are: 1. To compare the craving-reducing effects of "upregulation" and "downregulation" of craving while looking at pictures related to cigarette smoking during rTMS versus no regulation of craving while looking at neutral pictures unrelated to smoking. 'Upregulation" is thinking about the immediate positive experience of smoking. "Downregulation" is thinking about the long-term negative consequences of smoking. 2. To examine changes in brain activity that accompany craving reductions produced by rTMS paired with upregulation and downregulation of craving while looking at pictures related to cigarette smoking versus no regulation of craving while looking at neutral pictures unrelated to smoking. Following screening for eligibility, participants will be trained on how to do upregulation and downregulation of craving. The participants will then participate in 3 testing sessions. In each session, the participants will receive rTMS at 20Hz in 50 trains (2000 pulses total), followed immediately by fMRI. Sessions will take place 1-2 weeks apart and will differ in the type of thinking strategy participants will use while looking at pictures during the rTMS: - upregulation of craving while viewing smoking-related images - downregulation of craving while viewing smoking-related images - no regulation of craving while viewing neutral smoking-unrelated images The order of sessions will be randomized across participants.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06228235
Study type	Interventional
Source	West Virginia University
Contact	Mariya V Cherkasova, PhD
Phone	240-367-3068
Email	mariya.cherkasova@mail.wvu.edu
Status	Recruiting
Phase	N/A
Start date	April 16, 2024
Completion date	February 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04133064` - Assessment of the Pivot Breath Sensor: Single-Arm Cohort Study	N/A
Not yet recruiting	`NCT05442294` - "Juego de LLaves": Study Protocol of a Universal School-based Drug Use Prevention Program (PSIDUP)	N/A
Completed	`NCT04104152` - CSD190203: A Study to Determine Subject Puffing Patterns of an Electronic Nicotine Delivery System in an Ambulatory Setting	N/A
Completed	`NCT04808609` - Smoking Cessation Pilot for People Living With HIV (PLWH)	N/A
Enrolling by invitation	`NCT05554120` - The Next Step in Smoking Prevention: the Reduction of Tobacco Retail Outlets, a Comprehensive Policy Evaluation
Completed	`NCT05506046` - Messages About Reduced Nicotine in Combusted Tobacco Products	N/A
Active, not recruiting	`NCT05950074` - It´s Up To You: Update and Digitalization of a Universal School-based Prevention Intervention for Drug Initiation and Use	N/A
Completed	`NCT04089982` - Varenicline Light Smoking Pilot	Phase 4
Completed	`NCT05460650` - Acceptance and Usability of an App Promoting Healthy Behaviours Amongst Young Women at Increased Risk of Breast Cancer	N/A
Completed	`NCT05114863` - CSD200907: A Study to Assess Elements of Abuse Liability for a Heated Tobacco Product With Four Non-Combusted Cigarette Variants	N/A
Active, not recruiting	`NCT05049174` - Nurse-led Smoking Cessation Program With Follow-up in Healthy Life Centres: a Randomized Clinical Trial	N/A
Completed	`NCT04372290` - CSD190401: A Study to Assess Elements of Abuse Liability for Nicotine-containing Pouch Tobacco Products	N/A
Completed	`NCT04358705` - C-FLASH (Cigarillo Flavor and Abuse Liability, Attention, and Substitution in youtH)	N/A
Completed	`NCT04308434` - CSD190601: A Study to Determine Subject Puffing Patterns of Electronic Nicotine Delivery Systems in an Ambulatory Setting	N/A
Not yet recruiting	`NCT06373679` - Switch or Quit R01	N/A
Completed	`NCT04250727` - Switching to Potential Reduced Exposure Products in Adult Smokers	N/A
Completed	`NCT04311983` - Interventions to Help More Low-income Smokers Quit	N/A
Recruiting	`NCT06118502` - A Clinical Trial of Adaptive Treatment for Early Smoking Cessation Relapse	N/A
Completed	`NCT05210699` - CSD201201: Study to Assess Elements of Abuse Liability for Electronic Nicotine Delivery System P12	N/A
Recruiting	`NCT05108649` - Impact of Nicotine Messaging on Beliefs and Behavior	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.